Product Code: ETC6183895 | Publication Date: Sep 2024 | Updated Date: Apr 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The medical cannabis market in Australia operates within a highly regulated framework governed by the Therapeutic Goods Administration (TGA). It is driven by growing physician and patient awareness, increasing clinical trials, and the expansion of approved product categories for conditions such as chronic pain, epilepsy, and anxiety. The introduction of special access schemes and regulatory pathways has streamlined patient access. Imports continue to supplement domestic production, while local cultivation facilities are expanding to meet demand sustainably.
The medical cannabis segment in Australia is evolving with a surge in prescriptions and patient registrations. Physicians are becoming more open to prescribing cannabis-based treatments for conditions like chronic pain, epilepsy, and anxiety. Regulatory pathways are being streamlined to enhance patient access, and research initiatives on therapeutic efficacy are on the rise. Additionally, localized cultivation and production are gaining momentum to reduce dependence on imports and ensure product consistency and quality.
In the medical cannabis market, Australia faces the challenge of overcoming strict regulatory requirements and slow approval processes for medical cannabis products. Healthcare professionals are often hesitant to prescribe cannabis-based treatments due to a lack of comprehensive clinical evidence regarding their long-term efficacy and safety. Furthermore, the high cost of medical cannabis treatments, combined with the limited insurance coverage for such products, makes it inaccessible for many patients. Public perception and the stigma associated with cannabis use in medicine also remain a barrier to widespread adoption.
The legalized medical cannabis space in Australia offers substantial opportunities for pharmaceutical firms, biotech investors, and health-tech ventures. Companies involved in R&D of cannabis-derived therapeutics, especially for chronic conditions, are drawing interest. There is also scope for investments in prescription software platforms, patient access programs, and localized growing operations to minimize costs. Government support for medical cannabis trials makes this sector ripe for public-private partnership models.
Government policies in the legalized medical cannabis market are complex and vary by state, though the federal government has established a framework for medical cannabis use under the Therapeutic Goods Administration (TGA). The TGA regulates the importation, manufacture, and distribution of medical cannabis products. However, accessing medical cannabis is often a lengthy process, with patients needing to seek approval from healthcare professionals and, in some cases, undergo an application process for an import license. Additionally, the government maintains strict controls on the prescribing and use of medical cannabis, which can make it difficult for patients to access the treatments they need. Financial support from insurance companies and government subsidies remains limited, making the treatments expensive for many individuals.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Legalized Cannabis Medical Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Legalized Cannabis Medical Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Legalized Cannabis Medical Market - Industry Life Cycle |
3.4 Australia Legalized Cannabis Medical Market - Porter's Five Forces |
3.5 Australia Legalized Cannabis Medical Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Australia Legalized Cannabis Medical Market Revenues & Volume Share, By Form, 2021 & 2031F |
3.7 Australia Legalized Cannabis Medical Market Revenues & Volume Share, By End Use, 2021 & 2031F |
3.8 Australia Legalized Cannabis Medical Market Revenues & Volume Share, By Compound, 2021 & 2031F |
4 Australia Legalized Cannabis Medical Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Australia Legalized Cannabis Medical Market Trends |
6 Australia Legalized Cannabis Medical Market, By Types |
6.1 Australia Legalized Cannabis Medical Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Australia Legalized Cannabis Medical Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 Australia Legalized Cannabis Medical Market Revenues & Volume, By Cannabis Herb, 2021- 2031F |
6.1.4 Australia Legalized Cannabis Medical Market Revenues & Volume, By Cannabis Resin, 2021- 2031F |
6.2 Australia Legalized Cannabis Medical Market, By Form |
6.2.1 Overview and Analysis |
6.2.2 Australia Legalized Cannabis Medical Market Revenues & Volume, By Raw, 2021- 2031F |
6.2.3 Australia Legalized Cannabis Medical Market Revenues & Volume, By Processed, 2021- 2031F |
6.3 Australia Legalized Cannabis Medical Market, By End Use |
6.3.1 Overview and Analysis |
6.3.2 Australia Legalized Cannabis Medical Market Revenues & Volume, By Recreational, 2021- 2031F |
6.3.3 Australia Legalized Cannabis Medical Market Revenues & Volume, By Medicinal, 2021- 2031F |
6.4 Australia Legalized Cannabis Medical Market, By Compound |
6.4.1 Overview and Analysis |
6.4.2 Australia Legalized Cannabis Medical Market Revenues & Volume, By THC-Dominant, 2021- 2031F |
6.4.3 Australia Legalized Cannabis Medical Market Revenues & Volume, By CBD-Dominant, 2021- 2031F |
6.4.4 Australia Legalized Cannabis Medical Market Revenues & Volume, By Balanced THC & CBD, 2021- 2031F |
7 Australia Legalized Cannabis Medical Market Import-Export Trade Statistics |
7.1 Australia Legalized Cannabis Medical Market Export to Major Countries |
7.2 Australia Legalized Cannabis Medical Market Imports from Major Countries |
8 Australia Legalized Cannabis Medical Market Key Performance Indicators |
9 Australia Legalized Cannabis Medical Market - Opportunity Assessment |
9.1 Australia Legalized Cannabis Medical Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Australia Legalized Cannabis Medical Market Opportunity Assessment, By Form, 2021 & 2031F |
9.3 Australia Legalized Cannabis Medical Market Opportunity Assessment, By End Use, 2021 & 2031F |
9.4 Australia Legalized Cannabis Medical Market Opportunity Assessment, By Compound, 2021 & 2031F |
10 Australia Legalized Cannabis Medical Market - Competitive Landscape |
10.1 Australia Legalized Cannabis Medical Market Revenue Share, By Companies, 2024 |
10.2 Australia Legalized Cannabis Medical Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |